Common side effects include nausea, constipation, diarrhea, or fatigue, especially during the initial dose adjustments
A previous pharmacovigilance study based on FAERS conducted an analysis of the potential risk between GLP-1RA and tumors and provided new real-world evidence for oncology safety information of GLP-1RA [Reference Yang, Lv, Yu, Mei, Xiang and Zhao12]
As the L-Carnitine is still hydroscopic in nature, care should be used to avoid exposure to moisture and to keep the cap tightly sealed on the bottle
Besides Kentucky, other Southeastern states with high rates of GLP-1 use include Alabama (1.7%), West Virginia (1.7%), and Georgia (1.6%)
References: Many patients maintain weight loss a year after stopping semaglutide and liraglutide